Jump to main content
Jump to site search


Inducible Bcl-2 Gene RNA Interference mediated by Aptamer-integrated HDV Ribozyme Switch

Abstract

The regulation of RNA interference (RNAi) could be powerful for studying temporal and dose-dependent effect of gene expression. In this study, we designed the hepatitis delta virus (HDV) ribozyme with an embedded theophylline aptamer as the sensor domain, and the pri-miRNA of endogenous gene Bcl-2 as effector domain to engineer a RNAi-regulatory device in MCF-7 cells. The system allowed us to control gene expression by adding theophylline into the culture media in dose dependent fashion. This is the first application of HDV ribozyme switch to activate RNAi for modulating an endogenous gene in mammalian cells. The platform sets the stage for investigations of other endogenous genes that regulate various biological functions such as differentiation, cell division or cell death, and provides promising interface with other universal RNAi-based decision-making circuits that operate in mammalian cells. It can be used to study more genes associated with cancers and screen for potential drug targets for gene therapy.

Back to tab navigation
Please wait while Download options loads

Supplementary files

Publication details

The article was received on 15 Feb 2017, accepted on 07 May 2017 and first published on 11 May 2017


Article type: Paper
DOI: 10.1039/C7IB00029D
Citation: Integr. Biol., 2017, Accepted Manuscript
  •   Request permissions

    Inducible Bcl-2 Gene RNA Interference mediated by Aptamer-integrated HDV Ribozyme Switch

    Y. Zhang, J. Wang, H. Cheng, N. Sun, M. Liu, Z. Wu and R. Pei, Integr. Biol., 2017, Accepted Manuscript , DOI: 10.1039/C7IB00029D

Search articles by author